These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26198370)

  • 21. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.
    Ostermann H; Blasi F; Medina J; Pascual E; McBride K; Garau J;
    J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
    Duane TM; Capitano B; Puzniak LA; Biswas P; Joshi M
    Surg Infect (Larchmt); 2013 Aug; 14(4):401-7. PubMed ID: 23859675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
    Bounthavong M; Hsu DI
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):683-98. PubMed ID: 23252352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
    Bounthavong M; Hsu DI; Okamoto MP
    Int J Clin Pract; 2009 Mar; 63(3):376-86. PubMed ID: 19222624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections.
    Logman JF; Stephens J; Heeg B; Haider S; Cappelleri J; Nathwani D; Tice A; van Hout BA
    Curr Med Res Opin; 2010 Jul; 26(7):1565-78. PubMed ID: 20429820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management and outcome of adults with skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital in central Taiwan.
    Teh SH; Chi CY; Lin PC; Ho CM; Chou CH; Tsai CT; Wang JH; Ho MW
    J Microbiol Immunol Infect; 2015 Oct; 48(5):497-503. PubMed ID: 25446039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Napolitano LM
    Surg Infect (Larchmt); 2008; 9 Suppl 1():s17-27. PubMed ID: 18844471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection.
    Bally M; Dendukuri N; Sinclair A; Ahern SP; Poisson M; Brophy J
    Int J Antimicrob Agents; 2012 Dec; 40(6):479-95. PubMed ID: 23102749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
    Caffrey AR; Morrill HJ; Puzniak LA; Laplante KL
    Pharmacotherapy; 2014 May; 34(5):473-80. PubMed ID: 24420846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications.
    Tong MC; Wisniewski CS; Wolf B; Bosso JA
    Pharmacotherapy; 2016 Jul; 36(7):731-9. PubMed ID: 27208687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
    Lipsky BA; Itani KM; Weigelt JA; Joseph W; Paap CM; Reisman A; Myers DE; Huang DB
    Int J Infect Dis; 2011 Feb; 15(2):e140-6. PubMed ID: 21134775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
    Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
    Dodds TJ; Hawke CI
    ANZ J Surg; 2009 Sep; 79(9):629-35. PubMed ID: 19895519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.
    Meddles-Torres C; Hu S; Jurgens C
    J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin Use in Patients Discharged From the Emergency Department: A Retrospective Observational Cohort Study.
    Mueller K; McCammon C; Skrupky L; Fuller BM
    J Emerg Med; 2015 Jul; 49(1):50-7. PubMed ID: 25802166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.
    Weigelt J; Itani K; Stevens D; Lau W; Dryden M; Knirsch C;
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2260-6. PubMed ID: 15917519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of empiric antimicrobial treatments for skin and soft tissue infections in newly hospitalized patients.
    Yazdani C; Hanna N
    J Pharm Pract; 2014 Feb; 27(1):53-60. PubMed ID: 24076599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.